LuậnP. V., TùngN. Đình, HảiN. M. and TiếnN. Đạo (2024) “Compare the effectiveness of afatinib and gefitinib as first-line treatment in patients with advanced stage non-small cell lung cancer haboring common EGFR mutations: Real-world data on PFS”, Tạp chí Y Dược lâm sàng 108, 19(5). doi: 10.52389/ydls.v19i5.2265.